EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024

Lin Lin, Fei Dai, Jinjin Wei, Zheng Chen

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000535560 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Lin Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Huashan Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Arachidonate 5-Lipoxygenase, Asthma, Arachidonic Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: 5-Oxo-6,8,11,14-eicosatetraenoic acid (5-Oxo-ETE) is a metabolite of arachidonic acid shown to promote biological activities in different cell types. Summary: 5-Oxo-ETE is synthesized from the 5-lipoxygenase product 5S-HETE (5S-hydroxy-6,8,11,14-eicosatetraenoic acid) in the presence of the nicotinamide adenine dinucleotide phosphate (NADP)+-dependent enzyme 5-hydroxyeicosanoid dehydrogenase (5-HEDH). Under some conditions that promote oxidation of NADPH to NADP+, such as the respiratory burst in phagocytic cells, eosinophils, and neutrophils, oxidative stress in monocytes and dendritic cells, and cell death, 5-Oxo-ETE synthesis can be dramatically increased. In addition, 5-Oxo-ETE can also be formed in the absence of 5-lipoxygenase in cells through transcellular biosynthesis by inflammatory cell-derived 5S-HETE. This compound performs its biological activities by the highly selective Gi/o-coupled OXE receptor, which is highly expressed on eosinophils, neutrophils, basophils, and monocytes. As such, 5-Oxo-ETE is a potent chemoattractant for these inflammatory cells, especially for eosinophils. Key Messages: Although the pathophysiological role of 5-Oxo-ETE is not clearly understood, 5-Oxo-ETE may be a significant mediator in allergic diseases, such as allergic asthma, allergic rhinitis, and atopic dermatitis. And targeting the OXE receptor may be a novel therapy for this kind of inflammatory condition. Nowadays, selective OXE receptor antagonists are currently under investigation and could become potential therapeutic agents in allergy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arachidonate 5-LipoxygenaseAsthmaArachidonic AcidsHumansArachidonic AcidNADPHydroxyeicosatetraenoic Acids

Stichwörter der Autor:innen

5-Oxo-6,8,11,14-eicosatetraenoic acidAllergyAntagonistInflammationOXE receptor

Substanzen

5-oxo-6,8,11,14-eicosatetraenoic acidArachidonic AcidArachidonate 5-LipoxygenaseNADPHydroxyeicosatetraenoic AcidsArachidonic Acids

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Huashan Hospital of Fudan University, Shanghai, China.
  • Department of Allergy and Immunology, Huashan Hospital of Fudan University, Shanghai, China.
  • Research Center of Allergy and Dieseases, Fudan University, Shanghai, China.

Zitieren

APA

Lin, L., Dai, F., Wei, J., & Chen, Z. (2024). Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024. International Archives of Allergy and Immunology. https://doi.org/10.1159/000535560

Vancouver

Lin L, Dai F, Wei J, Chen Z. Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024. International Archives of Allergy and Immunology. 2024. doi:10.1159/000535560

BibTeX
@article{Lin2024,
  author = {Lin, Lin and Dai, Fei and Wei, Jinjin and Chen, Zheng},
  title = {Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000535560}
}
Kostenlos starten →